Results 131 to 140 of about 37,499 (232)

Author Correction: Proceedings of the world summit on parkinson's disease. [PDF]

NPJ Parkinsons Dis
Mantri S, Ghilardi MF, Lessard N, Norcini M, Di Rocco A, Wallock K, Lehr J, Okun MS, World Summit Steering Committee.   +8 more
europepmc   +1 more source

New dosing schedules in pre-treated patients with metastatic colorectal cancer. [PDF]

J Gastrointest Oncol
Pfeiffer P, Tarpgaard LS.
europepmc   +1 more source

Viewers'' Opinion of SDH in Europe::the UK

, 2012
Romero Fresco, Pablo
core  

Amivantamab, a bispecific epidermal growth factor receptor and mesenchymal-epithelial transition factor inhibitor, associated with ulcerative intertrigo. [PDF]

JAAD Case Rep
Concannon HR, Ku RG, Brazel M, Selim MA, Fresco A.   +4 more
europepmc   +1 more source

The Early Movers Clinician's Guide: Co-Designing a Resource for the 24-Hour Movement Guidelines in Paediatric Occupational Therapy. [PDF]

Child Care Health Dev
Taylor LG, Phillips SM, Tzvetkov D, Alvarez L, Tucker P.   +4 more
europepmc   +1 more source

Enriching stabilizing mutations through automated analysis of molecular dynamics simulations using BoostMut. [PDF]

Protein Sci
Korbeld KT, Fürst MJLJ.
europepmc   +1 more source

Refractory microsatellite-stable metastatic colorectal cancer: a comparison between botensilimab + balstilimab and current standard of care. [PDF]

Immunooncol Technol
Bengala E, Santini D, Picone V.
europepmc   +1 more source

Universalist, user-centred, and proactive approaches in media accessibility

, 2023
Romero Fresco, Pablo, G. M. Greco, P. Romero Fresco, Greco, Gian Maria   +2 more
core  

Analysis of fruquintinib in patients with metastatic colorectal cancer who were enrolled in Spain: results from the global FRESCO-2 study. [PDF]

ESMO Gastrointest Oncol
Garcia-Carbonero R, Elez E, García-Alfonso P, Cubillo Gracían A, López López R, Jimenez-Fonseca P, Limón Mirón ML, Dasari A, Lonardi S, Zhu H, Chen L, Yang Z, Schelman WR, Tabernero J.   +13 more
europepmc   +1 more source

FRESCO-2 trial and fruquintinib: A clearer picture of the control arm. [PDF]

Transl Oncol
Ranganathan S, Haslam A, Olivier T, Prasad V.   +3 more
europepmc   +1 more source